Nε-(Carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vessels

This publication has 32 references indexed in Scilit:

• Increased accumulation of the glycoxidation product Nε-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2004
• N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
  Journal of Biological Chemistry, 1999
• The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation
  Journal of Clinical Investigation, 1999
• Nɛ-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress
  Atherosclerosis, 1999
• Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.
  Journal of Clinical Investigation, 1997
• The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions
  Journal of Biological Chemistry, 1996
• Role of oxidative stress in development of complications in diabetes
  Diabetes, 1991
• Age-dependent accumulation of N.epsilon.-(carboxymethyl)lysine and N.epsilon.-(carboxymethyl)hydroxylysine in human skin collagen
  Biochemistry, 1991
• Effect of lanthanum chloride on established atherosclerosis in the cholesterol-fed rabbit. Mitral valve as a site for assessment of treatment effects.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
• Intramural stress as a causative factor in atherosclerotic lesions of the aortic valve
  Atherosclerosis, 1985